Literature DB >> 8376833

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

L G Rudenko1, A N Slepushkin, A S Monto, A P Kendal, E P Grigorieva, E P Burtseva, A R Rekstin, A L Beljaev, V E Bragina, N Cox.   

Abstract

Children aged 7-14 years in Novgorod, Russia, were given Russian live cold-adapted or inactivated influenza vaccines or placebo over a 2-year period. Schools were randomly assigned as a whole to one of the preparations. In the first year, the vaccines were bivalent, containing types A (H3N2) and A (H1N1) components. In the second year, the vaccines also contained a type B component. In the first year, all viruses isolated were type A (H3N2); in the second, about three-quarters of the isolates were type B and the rest type A (H1N1). During both years, the vaccines protected the vaccinated children. Where significant differences existed, the live attenuated vaccine was more protective than the inactivated. Vaccination rates in schools in which live attenuated vaccines had been used were inversely related to illness rates of staff and unvaccinated children, suggesting that viral transmission had been reduced by the vaccine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376833     DOI: 10.1093/infdis/168.4.881

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

Review 1.  Pneumococcal and influenza vaccination: current situation and future prospects.

Authors:  F Horwood; J Macfarlane
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

2.  Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza.

Authors:  Nimalan Arinaminpathy; Oliver Ratmann; Katia Koelle; Suzanne L Epstein; Graeme E Price; Cecile Viboud; Mark A Miller; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-07       Impact factor: 11.205

3.  H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.

Authors:  Irina Isakova-Sivak; Marina Stukova; Mariana Erofeeva; Anatoly Naykhin; Svetlana Donina; Galina Petukhova; Victoria Kuznetsova; Irina Kiseleva; Tatiana Smolonogina; Irina Dubrovina; Maria Pisareva; Alexandra Nikiforova; Maureen Power; Jorge Flores; Larisa Rudenko
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds.

Authors:  L G Rudenko; N I Lonskaya; A I Klimov; R I Vasilieva; A Ramirez
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

5.  Private Pediatric Clinic Characteristics Associated with Influenza Immunization Efforts in the State of Georgia: A Pilot Evaluation.

Authors:  Karen Pazol; Julie A Gazmararian; Mila M Prill; Emily M O'Malley; Deborah Jelks; Margaret S Coleman; Alan R Hinman; Walter A Orenstein
Journal:  Open Health Serv Policy J       Date:  2008-01-01

6.  Influenza vaccination rates of children in households with high-risk adults.

Authors:  Ru-Chien Chi; Gayle E Reiber; Benjamin A Lipsky; Edward J Boyko; Kathleen M Neuzil
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

7.  Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66.

Authors:  Erich Hoffmann; Kutubuddin Mahmood; Zhongying Chen; Chin-Fen Yang; Joshua Spaete; Harry B Greenberg; M Louise Herlocher; Hong Jin; George Kemble
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.

Authors:  Yumiko Matsuoka; Amorsolo Suguitan; Marlene Orandle; Myeisha Paskel; Kobporn Boonnak; Donald J Gardner; Friederike Feldmann; Heinz Feldmann; Michael Marino; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

9.  Seasonal maintenance of influenza vaccine-induced antibody response in kidney transplant recipients.

Authors:  Kelly A Birdwell; Mine R Ikizler; Li Wang; Daniel W Byrne; Edith C Sannella; Peter F Wright; T Alp Ikizler
Journal:  Am J Nephrol       Date:  2012-08-17       Impact factor: 3.754

10.  Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998-2004.

Authors:  R Sebastian; D M Skowronski; M Chong; J Dhaliwal; J S Brownstein
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.